Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Echinocandins

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Echinocandins:

Pubmed Logo
Wild-type MIC Distributions and Epidemiological Cutoff Values (ECVs) for the Echinocandins and Candida spp.
We tested a global collection of Candida spp. against anidulafungin,...
20th November, 2009
Departments of Pathology, and Medicine, University of Iowa Carver College J Clin Microbiol. 2009 Nov 18.
DOI Direct Link
The effects of an hsp90 inhibitor on the paradoxical effect.
It is important to conserve the effectiveness of antifungal agents because...
11th November, 2009
Department of Chemotherapy and Mycoses, National Institute of Infectious Jpn J Infect Dis. 2009 Sep;62(5):392-3.
Micafungin - the newest echinocandin.
Micafungin is one of three currently FDA-approved echinocandins. It has...
6th November, 2009
Mayo Clinic and Foundation, Division of Infectious Diseases, Rochester, MN Drugs Today (Barc). 2009 Jun;45(6):469-78.
Susceptibility testing of Candida species to echinocandins: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion and agar-dilution using RPMI and IsoSensitest medium.
This study compared nine susceptibility testing methods and 12 endpoints...
4th November, 2009
Unit of Mycology and Parasitology, Statens Serum Institut, Copenhagen, Antimicrob Agents Chemother. 2009 Nov 2.
DOI Direct Link
Terbinafine: a pharmacological and clinical review.
Terbinafine (TRB) is an allylamine antifungal agent that has been...
31st October, 2009
Wayne State University/John D. Dingell VA Medical Center, Expert Opin Pharmacother. 2009 Nov;10(16):2723-33.
DOI Direct Link

View more research publications.

Press Releases About Echinocandins:

BioPortfolio Logo
New Survey forecasts over 70% revenue growth in systematic antifungal 1st July, 2004 Datamonitor
New Survey forecasts over 70% revenue growth in systematic antifungal market over the next decade Pfizer, Merck & Co. and Fujisawa best positioned London - According to a new report* from

Echinocandins Patents:

USPTO Logo
US Patent No.Title
6585967 Adhesive treatment for tinea cruris
6727082 Assays and reagents for identifying anti-fungal agents, and uses related thereto
6740670 Thiazolidine derivatives and its use as antifungal agent
6743598 Methods for the identification of fungal glucose utilization inhibitors and antifungal agents
6746667 Adhesive treatment for tinea pedis

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Echinocandins scientists - we have details of around 114 individuals working on Echinocandins .


This page has been viewed 442 times
Recent Search Terms used to find this page: echinocandins 2009 | echinocandins 2009 | Echinocandins differences 2009 | candida eradication | echinocandins and cidal | echinocandins discovery | Micafungin new drug. Severe candidiasis a third echinocandin with life-threatening hepatotoxicity. | echinocandins | echinocandins | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Echinocandins across BioPortfolio, or for Echinocandins Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.